The socioeconomic burden of coronary heart disease in Korea

Hoo Sun Chang, Han Joong Kim, Chung Mo Nam, Seung Ji Lim, Young Hwa Jang, Sera Kim, Hye Young Kang

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea. Key words: Angina, Coronary disease, Cost of illness, Insurance claim, Myocardial infarction

Original languageEnglish
Pages (from-to)291-300
Number of pages10
JournalJournal of Preventive Medicine and Public Health
Volume45
Issue number5
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Korea
Coronary Disease
Costs and Cost Analysis
Premature Mortality
Cost of Illness
National Health Programs
Insurance
Myocardial Infarction
Angina Pectoris
International Classification of Diseases
Health Expenditures
Health Care Costs
Caregivers
Morbidity

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Chang, Hoo Sun ; Kim, Han Joong ; Nam, Chung Mo ; Lim, Seung Ji ; Jang, Young Hwa ; Kim, Sera ; Kang, Hye Young. / The socioeconomic burden of coronary heart disease in Korea. In: Journal of Preventive Medicine and Public Health. 2012 ; Vol. 45, No. 5. pp. 291-300.
@article{bf6d4cc18b3c497dae7ae3829b5012fb,
title = "The socioeconomic burden of coronary heart disease in Korea",
abstract = "Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3{\%}), followed by productivity loss due to morbidity and premature death (33.6{\%}), transportation (8.1{\%}), and informal caregiver costs (4.9{\%}). While medical cost was the predominant cost attribute in treating angina (74.3{\%} of the total cost), premature death was the largest cost attribute for patients with MI (66.9{\%}). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02{\%} of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea. Key words: Angina, Coronary disease, Cost of illness, Insurance claim, Myocardial infarction",
author = "Chang, {Hoo Sun} and Kim, {Han Joong} and Nam, {Chung Mo} and Lim, {Seung Ji} and Jang, {Young Hwa} and Sera Kim and Kang, {Hye Young}",
year = "2012",
month = "9",
day = "1",
doi = "10.3961/jpmph.2012.45.5.291",
language = "English",
volume = "45",
pages = "291--300",
journal = "Journal of Preventive Medicine and Public Health",
issn = "1975-8375",
publisher = "Korean Society for Preventive Medicine",
number = "5",

}

The socioeconomic burden of coronary heart disease in Korea. / Chang, Hoo Sun; Kim, Han Joong; Nam, Chung Mo; Lim, Seung Ji; Jang, Young Hwa; Kim, Sera; Kang, Hye Young.

In: Journal of Preventive Medicine and Public Health, Vol. 45, No. 5, 01.09.2012, p. 291-300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The socioeconomic burden of coronary heart disease in Korea

AU - Chang, Hoo Sun

AU - Kim, Han Joong

AU - Nam, Chung Mo

AU - Lim, Seung Ji

AU - Jang, Young Hwa

AU - Kim, Sera

AU - Kang, Hye Young

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea. Key words: Angina, Coronary disease, Cost of illness, Insurance claim, Myocardial infarction

AB - Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea. Key words: Angina, Coronary disease, Cost of illness, Insurance claim, Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84867619896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867619896&partnerID=8YFLogxK

U2 - 10.3961/jpmph.2012.45.5.291

DO - 10.3961/jpmph.2012.45.5.291

M3 - Article

C2 - 23091654

AN - SCOPUS:84867619896

VL - 45

SP - 291

EP - 300

JO - Journal of Preventive Medicine and Public Health

JF - Journal of Preventive Medicine and Public Health

SN - 1975-8375

IS - 5

ER -